According to our latest research, the global lung cancer therapeutics market size reached USD 28.3 billion in 2024, reflecting robust advancements in treatment modalities and rising incidence rates worldwide. The market is witnessing a healthy expansion, registering a CAGR of 8.2% during the forecast period. By 2033, the lung cancer therapeutics market is projected to attain a value of USD 56.1 billion.
https://growthmarketreports.co....m/report/lung-cancer